Novel Microdilution Method to Assess Double and Triple Antibiotic Combination Therapy In Vitro

Abstract EN

An in vitro microdilution method was developed to assess double and triple combinations of antibiotics.

Five antibiotics including ciprofloxacin, amikacin, ceftazidime, piperacillin, and imipenem were tested against 10 clinical isolates of Pseudomonas aeruginosa.

Each isolate was tested against ten double and nine triple combinations of the antibiotics.

A 96-well plate was used to test three antibiotics, each one alone and in double and triple combinations against each isolate.

The minimum bacteriostatic and bactericidal concentrations in combination were determined with respect to the most potent antibiotic.

An Interaction Code (IC) was generated for each combination, where a numerical value was designated based on the 2-fold increase or decrease in the MICs with respect to the most potent antibiotic.

The results of the combinations were verified by time-kill assay at constant concentrations of the antibiotics and in a chemostat.

Only 13% of the double combinations were synergistic, whereas 5% showed antagonism.

Forty-three percent of the triple combinations were synergistic with no antagonism observed, and 100% synergism was observed in combination of ciprofloxacin, amikacin, and ceftazidime.

The presented protocol is simple and fast and can help the clinicians in the early selection of the effective antibiotic therapy for treatment of severe infections.